Next week, markets will focus on September job creations (consensus: 82,500 positions, unemployment rate expected unchanged at 4.1%), August PCE inflation data (3.8% year-over-year, 3.4% core) and Micron’s earnings expected Wednesday night with a consensus EPS of $31.49 on revenue of $50.9 billion. Eli Lilly will also present clinical data on several obesity drug candidates at the annual meeting of the European Association for the Study of Diabetes. Traders are pricing in a 66% chance of another Fed rate hike in October and roughly 50-50 odds for an additional increase in December.
Source: Read the original article

